Cancer drug resistance is a serious threat in Bangladesh

Abstract

Cancer drug resistance is a serious issue in Bangladesh that must be addressed with effective solutions. The growth of resistant bacterial strains, inappropriate use of antimicrobials, and inadequate healthcare standards in Bangladesh have resulted in a severe problem with cancer medication resistance. A comprehensive strategy will be needed to address these problems, one that includes expanding knowledge of antibiotic resistance, bettering healthcare system regulation, and developing more potent cancer therapies.

Keywords

Cancer / Cancer drug resistance / Bangladesh

References

[1] Uddin AK, Sumon MA, Pervin S, Sharmin F. Cervical cancer in Bangladesh. South Asian J Cancer. 2023;12(1):36–38.

[2] Hussain SMA. Comprehensive update on cancer scenario of Bangladesh. South Asian J Cancer. 2013;2(4):279–284.

[3] www.who.int/publications/m/item/cancer-bgd-2020.

[4] gco.iarc.fr/today/data/factsheets/populations/50-bangladesh-fact-sheets.pdf.

[5] Emran TB, Shahriar A, Mahmud AR, et al. Multidrug resistance in cancer: understanding molecular mechanisms, immunoprevention and therapeutic approaches. Front Oncol. 2022;12:891652.

[6] Hoque R, Ahmed SM, Naher N, et al. Tackling antimicrobial resistance in Bangladesh: a scoping review of policy and practice in human, animal and environment sectors. PLoS One. 2020;15(1):e0227947.

[7] Farhan M. Insights on the Role of polyphenols in combating cancer drug resistance. Biomedicine. 2023;11(6):1709.

[8] Khan FA, Salim MH, du Cros P, et al. Effectiveness and safety of standardised shorter regimens for multidrug-resistant tuberculosis: individual patient data and aggregate data meta-analyses. Eur Respir J. 2017;50(1).

RIGHTS & PERMISSIONS

2024 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.